Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma
Sponsor: Nanfang Hospital, Southern Medical University
Summary
The investigators plan to develop a deep learning-based automatic interpretation model for Claudin18.2(CLDN18.2) using the institution's and multiple other centers' extensive pathological resources of digestive system adenocarcinomas. This study will not only strictly follow the latest domestic expert consensus and standards, but also aims to address current pain points in manual interpretation. It seeks to provide technical support for standardizing, objectifying, and streamlining CLDN18.2 testing, thereby advancing the application of precision medicine in the diagnosis and treatment of digestive system diseases. The project has clear clinical necessity and broad application prospects.
Official title: Development and Real-World Validation of an Intelligent Interpretation Model for Claudin18.2 Protein Expression in Digestive System Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2025-10-01
Completion Date
2028-08
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Locations (2)
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Qianfoshan Hospital
Jinan, Shandong, China